B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling

REACTOME PATHWAY
Reactome: R-HSA-26446072 genes3 compounds

The Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling pathway (Reactome ID: R-HSA-2644607) involves 2 genes and is affected by 3 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

CUL1RBX1

Compounds Affecting Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling

#CompoundTargets HitStudies
1ninhydrin300
2candesartan cilexetil [Supplementary Concept]300
3Cetylpyridinium Cationic bactericidal surfactant used as300

About the Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling Pathway

The Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling pathway is catalogued in Reactome (ID: R-HSA-2644607) and involves 2 genes. In the BiohacksAI corpus, 3 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CUL1, RBX1.